| EPA027 | HIV-1 Vpu limits Fc-mediated effector functions in vivo | E-poster | Humoral immunity (including broadly neutralizing antibodies), Antibodies and B cells |
| EPA026 | Characterizing the effect of intracellular storage pools of RANTES/CCL5 on HIV infection in macrophages | E-poster | Innate immunity (including NK cells) |
| EPA025 | HLA-B*46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotypes | E-poster | Innate immunity (including NK cells) |
| EPA024 | The effects of in utero HIV and anti-retroviral therapy exposure on infant T-cell and monocyte activation, function and regulation of immune-modulatory pathways | E-poster | Innate immunity (including NK cells) |
| EPA023 | Immunotherapeutic blockades targeting LAG-3 and PD-1 immune checkpoint inhibitors on invariant Natural Killer T cells: implications in chronic HIV infection | E-poster | Innate immunity (including NK cells) |
| EPA022 | Impact of chronic HIV infection on NK cell response through the HLA-E/NKG2x axis | E-poster | Innate immunity (including NK cells) |
| EPA021 | HIV-1 subtype C Vif transmitted/founder (T/F) variants preferentially degrade APOBEC3G over APOBEC3F | E-poster | Innate immunity (including NK cells) |
| EPA020 | Penile barrier integrity and a mechanistic search for the effectiveness of medical male circumcision in preventing HIV acquisition | E-poster | Correlates of HIV susceptibility, and progression versus control (biomarkers and genetics) |
| EPA018 | Alterations in B lymphocyte subsets in virologically suppressed HIV-positive individuals did not impact 17DD yellow fever vaccine immunogenicity ' ANRS 12403 | E-poster | Systemic immune activation and inflammation |
| EPA016 | IL-32γ induces the expression of a heart-homing signature on a subset of memory CD4 T-cells with increased permissiveness to HIV-1 infection: a potential role in cardiovascular disease | E-poster | Systemic immune activation and inflammation |